Investing.com - Financial Markets Worldwide

Ensol Biosciences Inc (140610)

KONEX
Currency in KRW
29,850
-100(-0.33%)
Closed·
140610 Scorecard
Full Analysis
Stock generally trades with high price volatility
140610 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
28,05029,900
52 wk Range
5,01038,800
Key Statistics
Edit
Bid/Ask
29,750.00 / 29,850.00
Prev. Close
29,950
Open
29,900
Day's Range
28,050-29,900
52 wk Range
5,010-38,800
Volume
21.79K
Average Volume (3m)
32.57K
1-Year Change
375.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
140610 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 7
Suffers from weak gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Ensol Biosciences Inc Company Profile

Ensol Biosciences Inc., a biopharmaceutical company, develops bio drugs for the treatment of degenerative disc, osteoarthritis, cancer, type 1 diabetes, and Alzheimer's dementia diseases. The company’s drug pipeline includes Peniel 2000, which is in Phase III clinical trial for the treatment of degenerative disc disease; Engedi 1000 that is in Phase II clinical trial for the treatment of osteoarthritis; and EAD100, a drug for animal osteoarthritis. It also develops anticancer drugs, such as Charis 1000, which is in Phase I clinical trial for the treatment of triple negative breast cancer; Moriah 1000 that is in pre-clinical stage for the treatment of Alzheimer’s disease; Shiloah 1000, which is in pre-clinical stage for the treatment of type 1 diabetes; Allose 1000 that is in pre-clinical stage for the treatment of atopic dermatitis; EAD200, a drug for animal anti-cancer drug; and EAD300 for the treatment of porcine reproductive and respiratory syndrome. In addition, the company offers contract drug development; chemistry, manufacturing, and controls contract drug development; and material synthesis and analysis services. Further, it provides KISDD, a knowledge-based in silico drug discovery platform for the screening of new drug candidates for the treatment of a disease; and ETONS, an Ensol Trans-Omics network system. The company was formerly known as Ensoltek Co., Ltd. and changed its name to Ensol Biosciences Inc. in August 2015. Ensol Biosciences Inc. was founded in 2001 and is headquartered in Daejeon, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
0
Market
South Korea

Compare 140610 to Peers and Sector

Metrics to compare
140610
Peers
Sector
Relationship
P/E Ratio
0.0x−4.8x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x19.2x3.2x
Upside (Analyst Target)
0.0%23.6%41.6%
Fair Value Upside
Unlock1.1%6.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

140610 Income Statement

FAQ

What Stock Exchange Does Ensol Biosciences Trade On?

Ensol Biosciences is listed and trades on the Korea New Exchange stock exchange.

What Is the Stock Symbol for Ensol Biosciences?

The stock symbol for Ensol Biosciences is "140610."

What Is the Ensol Biosciences Market Cap?

As of today, Ensol Biosciences market cap is 370.73B.

What Is Ensol Biosciences's Earnings Per Share (TTM)?

The Ensol Biosciences EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 140610 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Ensol Biosciences Stock Split?

Ensol Biosciences has split 0 times.

How Many Employees Does Ensol Biosciences Have?

Ensol Biosciences has 0 employees.

What is the current trading status of Ensol Biosciences (140610)?

As of 28 Jul 2025, Ensol Biosciences (140610) is trading at a price of 29,850.00, with a previous close of 29,950.00. The stock has fluctuated within a day range of 28,050.00 to 29,900.00, while its 52-week range spans from 5,010.00 to 38,800.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.